UnitedHealth Group Inc.'s Senior Unsecured Notes Rated 'A+' - S&P Global Ratings’ Credit Research

UnitedHealth Group Inc.'s Senior Unsecured Notes Rated 'A+'

UnitedHealth Group Inc.'s Senior Unsecured Notes Rated 'A+' - S&P Global Ratings’ Credit Research
UnitedHealth Group Inc.'s Senior Unsecured Notes Rated 'A+'
Published Mar 19, 2024
3 pages (1366 words) — Published Mar 19, 2024
Price US$ 150.00  |  Buy this Report Now

About This Report

  
Abstract:

NEW YORK (S&P Global Ratings) March 19, 2024--S&P Global Ratings today assigned its 'A+' issue rating to UnitedHealth Group Inc.'s new senior unsecured notes, which the company will issue in three-, five-, seven-, 10-, 30-, and 40-year tranches. The debt issuance does not affect our 'A+' long-term issuer credit rating on UnitedHealth Group (UNH). UnitedHealth Group will use the debt proceeds for general corporate purposes, including repaying its average outstanding commercial paper borrowings ($4.5-$5 billion) and refinancing its $1 billion of 0.55% senior notes due May 2024. We anticipate that financial leverage, including this transaction, will remain 41%-42% in 2024, due to higher debt needs, such as funding the Amedisys acquisition (expected to close in 2024). The company has also

  
Brief Excerpt:

...March 19, 2024 NEW YORK (S&P Global Ratings) March 19, 2024--S&P Global Ratings today assigned its 'A+' issue rating to UnitedHealth Group Inc.'s new senior unsecured notes, which the company will issue in three-, five-, seven-, 10-, 30-, and 40-year tranches. The debt issuance does not affect our 'A+' long-term issuer credit rating on UnitedHealth Group (UNH). UnitedHealth Group will use the debt proceeds for general corporate purposes, including repaying its average outstanding commercial paper borrowings ($4.5-$5 billion) and refinancing its $1 billion of 0.55% senior notes due May 2024. We anticipate that financial leverage, including this transaction, will remain 41%-42% in 2024, due to higher debt needs, such as funding the Amedisys acquisition (expected to close in 2024). The company has also guided toward $9 billion of share repurchases this year and $7 billion in dividends. Our leverage forecast also incorporates the divestiture of the group's operations in Brazil (primarily consisting...

  
Report Type:

Ratings Action

Ticker
Issuer
GICS
Managed Health Care (35102030)
Sector
Global Issuers
Country
Region
Format:
PDF Adobe Acrobat
Buy Now

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "UnitedHealth Group Inc.'s Senior Unsecured Notes Rated 'A+'" Mar 19, 2024. Alacra Store. May 09, 2025. <http://www.alacrastore.com/s-and-p-credit-research/UnitedHealth-Group-Inc-s-Senior-Unsecured-Notes-Rated-A-3140657>
  
APA:
S&P Global Ratings’ Credit Research. (). UnitedHealth Group Inc.'s Senior Unsecured Notes Rated 'A+' Mar 19, 2024. New York, NY: Alacra Store. Retrieved May 09, 2025 from <http://www.alacrastore.com/s-and-p-credit-research/UnitedHealth-Group-Inc-s-Senior-Unsecured-Notes-Rated-A-3140657>
  
US$ 150.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.